Synmosa Biopharma (4114) — Free Cash Flow Generation Index
Synmosa Biopharma (4114) has a Free Cash Flow Generation Index of 0.68x as of December 2025. Free cash flow of NT$126.26 Million represents 1% of operating cash flow (NT$185.72 Million). See working capital position of Synmosa Biopharma to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Synmosa Biopharma Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Synmosa Biopharma across 9 annual periods. Explore 4114 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Synmosa Biopharma (2015–2025)
Year-by-year Free Cash Flow Generation Index for Synmosa Biopharma. For the full company profile including market capitalisation, see 4114 company net worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | NT$130.44 Million | NT$411.57 Million | NT$281.13 Million | ▼ -51.6% |
| 2024 | 0.65x | NT$510.97 Million | NT$780.62 Million | NT$269.65 Million | ▲ +38.4% |
| 2023 | 0.47x | NT$242.16 Million | NT$511.93 Million | NT$269.77 Million | ▼ -33.1% |
| 2022 | 0.71x | NT$445.92 Million | NT$630.25 Million | NT$129.29 Million | ▲ +4.0% |
| 2021 | 0.68x | NT$302.17 Million | NT$444.29 Million | NT$93.06 Million | ▲ +124.1% |
| 2020 | 0.30x | NT$77.20 Million | NT$254.40 Million | NT$154.41 Million | ▲ +101.4% |
| 2018 | -21.89x | NT$-350.16 Million | NT$16.00 Million | NT$314.43 Million | ▼ -883.9% |
| 2016 | 2.79x | NT$660.40 Million | NT$236.48 Million | NT$423.92 Million | ▼ -83.2% |
| 2015 | 16.65x | NT$392.86 Million | NT$23.60 Million | NT$369.26 Million | — |